AZ CEO Pascal Soriot recorded an interview with PharmaDispatch during his recent trip to Australia.
In the first of a two-part interview, he discusses the new AstraZeneca, his personal affinity with 'home' in Australia and how it 'breaks his heart' governments here have not done more to grow innovative industries.
AZ's Pascal Soriot: 'My Australia and the new AstraZeneca'
January 31, 2019 BioPharmaDispatch ExecutiveNews of the Day
Latest Video
Georgia Forrest
New Stories
-
Anne Harris steps down after defining leadership during COVID and lasting impact on Medicines Australia
January 14, 2026 - - Latest News -
AusBiotech joins Trade Diversification Network to boost global life sciences partnerships
January 13, 2026 - - Australian Biotech -
Reread this document - even its redactions reveal that change might be coming
January 13, 2026 - - Latest News -
Johnson & Johnson the latest to sign 'Most Favored Nation' agreement with Trump administration
January 11, 2026 - - Latest News -
Reading between the reform lines - what the 2005 Cabinet papers can teach us today
January 11, 2026 - - Latest News -
New treatment listed on PBS, offering twice-yearly dosing for Australians with relapsing MS
January 9, 2026 - - Latest News -
The value of looking back and the importance of seeing the 'smoke signals' on reform
January 8, 2026 - - Latest News